Position in VREX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$569,801
+$7,514 QoQ
Shares Held
54,631
+3.1% QoQ
Ownership
0.130%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#66
of 186 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 18%
Shared 0%
None 82%
Common Shares in VREX Over Time
Shares Held
Position Value (USD)
Position in Medical Devices
Healthcare · as of Jun 30, 2026RHUMBLINE ADVISERS holds $1,265,447,675 across 84 Medical Devices names. VREX ranks #50 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABT |
Abbott Laboratories
|
2,820,543 | $255,936,071 | |
| 2 | SYK |
Stryker Corp
|
616,745 | $194,175,995 | |
| 3 | MDT |
Medtronic plc
|
2,213,044 | $173,126,432 | |
| 4 | BSX |
Boston Scientific Corp
|
2,641,843 | $112,753,859 | |
| 5 | EW |
Edwards Lifesciences Corp
|
1,096,770 | $99,213,814 | |
| 6 | DXCM |
Dexcom Inc
|
768,165 | $51,735,912 | |
| 7 | GEHC |
GE HealthCare Technologies Inc.
|
755,006 | $48,327,934 | |
| 8 | STE |
STERIS plc
|
217,541 | $45,807,608 |
All Filings in VREX
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $569,801 | 54,631 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $562,287 | 52,996 | Shares | Sole | 2026-05-12 | |
| 2025-12-31 | $626,024 | 53,736 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $751,502 | 60,605 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $535,979 | 61,820 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $685,861 | 59,126 | Shares | Sole | 2025-05-29 | |
| 2024-12-31 | $893,316 | 61,228 | Shares | Sole | 2025-05-29 | |
| 2024-09-30 | $747,860 | 62,740 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $1,903,837 | 129,249 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $2,424,784 | 133,966 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $2,762,313 | 134,747 | Shares | Sole | 2024-02-08 | |
| 2023-09-30 | $2,555,665 | 136,012 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $3,206,274 | 136,032 | Shares | Sole | 2023-08-08 | |
| 2023-03-31 | $2,458,505 | 135,157 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $2,599,881 | 128,073 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $2,593,793 | 122,696 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $2,507,656 | 117,235 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $2,381,243 | 111,848 | Shares | Sole | 2022-05-12 | |
| 2021-12-31 | $3,642,983 | 115,467 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $3,365,388 | 119,340 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $3,607,424 | 134,505 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $2,925,316 | 142,768 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $2,371,912 | 142,201 | Shares | Sole | 2021-02-10 | |
| 2020-09-30 | $1,613,392 | 126,839 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $2,020,979 | 133,398 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $3,058,332 | 134,669 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||